Citation: Fm. Reischies et al., Brain atrophy parameters of very old subjects in a population-based samplewith and without dementia syndrome, EUR ARCH PS, 251(3), 2001, pp. 99-104
Authors:
Lunt, M
Masaryk, P
Scheidt-Nave, C
Nijs, J
Poor, G
Pois, H
Falch, JA
Hammermeister, G
Reid, DM
Benevolenskaya, L
Weber, K
Cannata, J
O'Neill, TW
Felsenberg, D
Silman, AJ
Reeve, J
Citation: M. Lunt et al., The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: The EVOS study, OSTEOPOR IN, 12(8), 2001, pp. 688-698
Authors:
Ismail, AA
Cockerill, W
Cooper, C
Finn, JD
Abendroth, K
Parisi, G
Banzer, D
Benevolenskaya, LI
Bhalla, AK
Armas, JB
Cannata, JB
Delmas, PD
Dequeker, J
Dilsen, G
Eastell, R
Ershova, O
Falch, JA
Felsch, B
Havelka, S
Hoszowski, K
Jajic, I
Kragl, U
Johnell, O
Vaz, AL
Lorenc, R
Lyritis, G
Marchand, F
Masaryk, P
Matthis, C
Miazgowski, T
Pols, HAP
Poor, G
Rapado, A
Raspe, HH
Reid, DM
Reisinger, W
Janott, J
Scheidt-Nave, C
Stepan, J
Todd, C
Weber, K
Woolf, AD
Ambrecht, G
Gowin, W
Felsenberg, D
Lunt, M
Kanis, JA
Reeve, J
Silman, AJ
O'Neill, TW
Citation: Aa. Ismail et al., Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: Results from the European Prospective Osteoporosis Study, OSTEOPOR IN, 12(2), 2001, pp. 85-90
Authors:
McGuigan, FEA
Armbrecht, G
Smith, R
Felsenberg, D
Reid, DM
Ralston, SH
Citation: Fea. Mcguigan et al., Prediction of osteoporotic fractures by bone densitometry and COLIA1 genotyping: A prospective, population-based study in men and women, OSTEOPOR IN, 12(2), 2001, pp. 91-96
Authors:
Homminga, J
Weinans, H
Gowin, W
Felsenberg, D
Huiskes, R
Citation: J. Homminga et al., Osteoporosis changes the amount of vertebral trabecular bone at risk of fracture but not the vertebral load distribution, SPINE, 26(14), 2001, pp. 1555-1560
Authors:
Delmas, PD
Pornel, B
Felsenberg, D
Stakkestad, JA
Radowicki, S
Garnero, P
Hardy, P
Dain, MP
Petitier, B
Citation: Pd. Delmas et al., Three-year follow-up of the use of transdermal 17 beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women, AM J OBST G, 184(2), 2001, pp. 32-40
Authors:
Leidig-Bruckner, G
Limberg, B
Felsenberg, D
Bruckner, T
Holder, S
Kather, A
Miksch, J
Wuster, C
Ziegler, R
Scheidt-Nave, C
Citation: G. Leidig-bruckner et al., Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: A population survey of older men and women, OSTEOPOR IN, 11(2), 2000, pp. 102-119
Authors:
Schnitzer, T
Bone, HG
Crepaldi, G
Adami, S
McClung, M
Kiel, D
Felsenberg, D
Recker, RR
Tonino, RP
Roux, C
Pinchera, A
Foldes, AJ
Greenspan, SL
Levine, MA
Emkey, R
Santora, AC
Kaur, A
Thompson, DE
Yates, J
Orloff, JJ
Citation: T. Schnitzer et al., Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis, AGING-CLIN, 12(1), 2000, pp. 1-12
Authors:
Orwoll, E
Ettinger, M
Weiss, S
Miller, P
Kendler, D
Graham, J
Adami, S
Weber, K
Lorenc, R
Pietschmann, P
Vandormael, K
Lombardi, A
Adachi, JD
Bell, N
Body, JJ
Castro, A
Daifotis, A
Felsenberg, D
Gilchrist, N
Hoffman, A
Maricic, M
Rizzoli, R
Silverman, S
Valeriano, J
Citation: E. Orwoll et al., Alendronate for the treatment of osteoporosis in men, N ENG J MED, 343(9), 2000, pp. 604-610
Authors:
Delmas, PD
Pornel, B
Felsenberg, D
Garnero, P
Hardy, P
Pilate, C
Dain, MP
Citation: Pd. Delmas et al., A dose-ranging trial of a matrix transdermal 17 beta-estradiol for the prevention of bone loss in early postmenopausal women, BONE, 24(5), 1999, pp. 517-523
Authors:
Lin, JC
Grampp, S
Link, T
Kothari, M
Newitt, DC
Felsenberg, D
Majumdar, S
Citation: Jc. Lin et al., Fractal analysis of proximal femur radiographs: Correlation with biomechanical properties and bone mineral density, OSTEOPOR IN, 9(6), 1999, pp. 516-524
Authors:
Pols, HAP
Felsenberg, D
Hanley, DA
Stepan, J
Munoz-Torres, M
Wilkin, TJ
Qin-sheng, G
Galich, AM
Vandormael, K
Yates, AJ
Stych, B
Citation: Hap. Pols et al., Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study, OSTEOPOR IN, 9(5), 1999, pp. 461-468
Authors:
Ismail, AA
Cooper, C
Felsenberg, D
Varlow, J
Kanis, JA
Silman, AJ
O'Neill, TW
Citation: Aa. Ismail et al., Number and type of vertebral deformities: Epidemiological characteristics and relation to back pain and height loss, OSTEOPOR IN, 9(3), 1999, pp. 206-213
Authors:
Schneider, PF
Fischer, M
Allolio, B
Felsenberg, D
Schroder, U
Semler, J
Ittner, JR
Citation: Pf. Schneider et al., Alendronate increases bone density and bone strength at the distal radius in postmenopausal women, J BONE MIN, 14(8), 1999, pp. 1387-1393
Authors:
Kroger, H
Lunt, M
Reeve, J
Dequeker, J
Adams, JE
Birkenhager, JC
Curiel, MD
Felsenberg, D
Hyldstrup, L
Kotzki, P
Laval-Jeantet, AM
Lips, P
Louis, O
Cano, RP
Reiners, C
Ribot, C
Ruegsegger, P
Schneider, P
Braillon, P
Pearson, J
Citation: H. Kroger et al., Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: The European quantitation of osteoporosis study, CALCIF TIS, 64(3), 1999, pp. 191-199
Citation: T. Sandor et al., Comments on the hypotheses underlying fracture risk assessment in osteoporosis as proposed by the World Health Organization, CALCIF TIS, 64(3), 1999, pp. 267-270